General measures and supportive therapy for pulmonary arterial hypertension: Updated recommendations from the Cologne Consensus Conference 2018.

Ekkehard Grünig, Nicola Benjamin, Ulrich Krüger, Harald Kaemmerer, Satenik Harutyunova, Karen M Olsson, Silvia Ulrich, Felix Gerhardt, Claus Neurohr, Armin Sablotzki, Michael Halank, Alberto M Marra, Hans-Joachim Kabitz, Günther Thimm, Klaus-Günther Fliegel, Hans Klose

Journal: International journal of cardiology 2019;272S():30-36

PMID: 30190156

Abstract

In the summer of 2016, delegates from the German Respiratory Society, the German Society of Cardiology and the German Society of Pediatric Cardiology met in Cologne, Germany, to define consensus-based practice recommendations for the management of patients with pulmonary arterial hypertension (PAH). These recommendations were built on the 2015 European Pulmonary Hypertension guidelines aiming at their practical implementation, considering country-specific issues, and including new evidence, where available. To this end, a number of working groups was initiated, one of which was specifically dedicated to general measures (i.e. physical activity/supervised rehabilitation, pregnancy/contraception, elective surgery, infection prevention, psychological support, travel) and supportive therapy (i.e. anticoagulants, diuretics, oxygen, cardiovascular medications, anaemia/iron deficiency, arrhythmias) for PAH. While the European guidelines provide detailed recommendations for the use of targeted PAH therapies as well as supportive care, detailed treatment decisions in routine clinical care may be challenging, and the relevance of supportive care is often not sufficiently considered. In addition, new evidence became available, thus requiring a thorough reevaluation of specific recommendations. The detailed results and recommendations of the working group on general measures and supportive therapy for PAH, which were last updated in the spring of 2018, are summarized in this article.

Copyright © 2018 Elsevier B.V. All rights reserved.

Address: Centre for Pulmonary Hypertension, Thoraxclinic at University Hospital Heidelberg and German Center for Lung Research (DZL), Heidelberg, Germany. Electronic address: [email protected].; Centre for Pulmonary Hypertension, Thoraxclinic at University Hospital Heidelberg and German Center for Lung Research (DZL), Heidelberg, Germany.; Department of Cardiology, Heart Centre Duisburg, Germany.; Department of Paediatric Cardiology and Congenital Heart Disease Munich, Germany.; Department of Respiratory Medicine, Hannover Medical School, German Centre for Lung Research (DZL), Hannover, Germany.; Clinic of Pulmonology, University Hospital Zurich, Switzerland.; Department of Cardiology, University Hospital Cologne, Germany.; Dept. of Internal Medicine V, Comprehensive Pneumology Center (CPC-M), Member of the German Center for Lung Research (DZL), University of Munich, Munich, Germany.; Clinic for Anesthesiology St. Georg Hospital, Leipzig, Germany.; Department of Pneumology, Carl Gustav Carus University Hospital, Dresden, Germany.; Centre for Pulmonary Hypertension, Thoraxclinic at University Hospital Heidelberg and German Center for Lung Research (DZL), Heidelberg, Germany; IRCCS S.D.N., Via Gianturco 113, 80143 Naples, Italy.; Department of Pneumology and Intensive Care Medicine, Academic Teaching Hospital, Klinikum Konstanz, Germany.; Patientenvereinigung Pulmonale Hypertonie e.V., Rheinstetten, Germany.; Department of Pneumology, University Hospital Hamburg-Eppendorf, Germany.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.